RxDoctor Payments Data

Allen Amorn

Clinical Cardiac Electrophysiology · Poland, OHNPI 1831310333

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (43.3%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Sanofi-aventis U.S. LLC at 32.8% of the total. Reporting peaked in 2022 at $10,856 and has fallen 88.7% since, to $1,226 in 2025.

$21,070in general payments, 2019–2025

Across 169 payments — averaging $124.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi-aventis U.S. LLC$7K
  • Abbott$5K
  • Biotronik Inc.$4K
  • Medtronic$1K
  • Boston Scientific$1K
  • Biosense Webster, Inc.$799
  • plus $3K from 18 others

What the payments were for

  • Consulting fees$460%
  • Speaking & faculty fees$6,60631%
  • Travel & lodging$5,28525%
  • Food & beverage$9,13343%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,070 in reported general payments places this provider in the 55th percentile of 159 clinical cardiac electrophysiology providers in Ohio.

See all clinical cardiac electrophysiology providers in Ohio →

Other clinical cardiac electrophysiology in Poland

See the full list for Ohio →

Where these figures come from

Is this you, or does something look wrong? →